Itoh, H., Ito, S., Rakugi, H., Okuda, Y., & Nishioka, S. (2019). Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: A single-arm, open-label study. Hypertens Res.

Itoh, Hiroshi, Sadayoshi Ito, Hiromi Rakugi, Yasuyuki Okuda, a Satoshi Nishioka. "Efficacy and Safety of Dosage-escalation of Low-dosage Esaxerenone Added to a RAS Inhibitor in Hypertensive Patients With Type 2 Diabetes and Albuminuria: A Single-arm, Open-label Study." Hypertens Res 2019.

Itoh, Hiroshi, et al. "Efficacy and Safety of Dosage-escalation of Low-dosage Esaxerenone Added to a RAS Inhibitor in Hypertensive Patients With Type 2 Diabetes and Albuminuria: A Single-arm, Open-label Study." Hypertens Res 2019.